Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin in type 2 diabetes
NCT00539890Phase 3Completed
- Sponsor
- MannKind
- Start
- Nov 2005
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Technosphere insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by MannKind. Primary endpoint: Mean change in HbA1c from baseline to treatment week 24. Started Nov 2005; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00539890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539890.